3rd most common cancer in the world. 2nd highest incidence cancer in eu
nearly 1.4m new colorectal cancer cases diagnosed in 2012 worldwide
2nd deadliest cancer in the EU and in US. 4th deadliest cancer in the world
3rd highest economic burden in the EU out of all cancers
Colorectal cancer creates a huge economic burden for many governments around the world. Efficient early detection methods can lead to improved outcomes and patient satisfaction during screening, diagnosis and monitoring.
We are currently developing Colon EpiCheck, a molecular diagnostic tool for colorectal cancer detection in blood samples based on our technology platform.